Canada-based cannabis company High Tide has entered the German medical cannabis market by purchasing a 51% stake in Frankfurt ...

Endometriosis, ovarian cysts, uterine fibroids and female orgasmic disorder were approved conditions to qualify for medical ...

Aggressive and misleading marketing is fuelling demand for medicinal cannabis. Here are some of the ways clinics bend the ...

Endometriosis, ovarian cysts, uterine fibroids and female orgasmic disorder are now on the list for medical conditions that ...

A new study at Columbia University Mailman School of Public Health found no changes in opioid outcomes among the general ...

The Illinois Department of Public Health has approved new conditions for treatment with medical cannabis, including ovarian ...

A new study found no changes in opioid outcomes among the general population with the states' passage of medical and recreational marijuana laws. However, the findings also show decreases in opioid ...

The Green administration needs to reevaluate its approach to the state-authorized use of cannabis before more legislative ...

A rise in cases of children ingesting edible cannabis concerns pediatric care professionals. Ingestion of tetrahyocannabinol ...

A state appeals court will hear oral arguments over a temporary restraining order issued against medical cannabis production ...

Findings from the latest New Zealand Drugs Trends Survey (NZDTS) reveal progress with the uptake of the Medicinal Cannabis ...

CALGARY – Cannabis retailer High Tide Inc. has signed a deal to acquire a 51 per cent stake in German medical cannabis ...